Livzon Pharmaceutical Group Inc (000513) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, Livzon Pharmaceutical Group Inc (000513) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥853.59 Million ≈ $124.91 Million USD) by net assets (CN¥15.37 Billion ≈ $2.25 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Livzon Pharmaceutical Group Inc - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Livzon Pharmaceutical Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Livzon Pharmaceutical Group Inc debt and liabilities for a breakdown of total debt and financial obligations.

Livzon Pharmaceutical Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Livzon Pharmaceutical Group Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Viscofan MC:VIS	0.066x
Lotus Health Group Co SHG:600186	0.052x
Genting Malaysia Bhd KLSE:4715	0.065x
Tidewater Inc NYSE:TDW	0.048x
Shanghai Yuyuan Tourist Mart Co Ltd SHG:600655	-0.030x
Axcelis Technologies Inc NASDAQ:ACLS	0.044x
Vista Energy S.A.B. de C.V. BA:VIST	0.106x
Shenzhen China Micro Semicon Co. Ltd. A SHG:688380	N/A

Annual Cash Flow Conversion Efficiency for Livzon Pharmaceutical Group Inc (1998–2024)

The table below shows the annual cash flow conversion efficiency of Livzon Pharmaceutical Group Inc from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Livzon Pharmaceutical Group Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥14.91 Billion ≈ $2.18 Billion	CN¥2.98 Billion ≈ $435.90 Million	0.200x	-13.06%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥3.39 Billion ≈ $496.68 Million	0.230x	+23.82%
2022-12-31	CN¥14.94 Billion ≈ $2.19 Billion	CN¥2.77 Billion ≈ $405.73 Million	0.186x	+39.65%
2021-12-31	CN¥14.31 Billion ≈ $2.09 Billion	CN¥1.90 Billion ≈ $278.37 Million	0.133x	-16.09%
2020-12-31	CN¥13.64 Billion ≈ $2.00 Billion	CN¥2.16 Billion ≈ $316.19 Million	0.158x	+10.04%
2019-12-31	CN¥12.28 Billion ≈ $1.80 Billion	CN¥1.77 Billion ≈ $258.59 Million	0.144x	+33.44%
2018-12-31	CN¥11.75 Billion ≈ $1.72 Billion	CN¥1.27 Billion ≈ $185.49 Million	0.108x	-7.90%
2017-12-31	CN¥11.23 Billion ≈ $1.64 Billion	CN¥1.32 Billion ≈ $192.55 Million	0.117x	-34.93%
2016-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥1.28 Billion ≈ $187.19 Million	0.180x	-6.67%
2015-12-31	CN¥4.81 Billion ≈ $703.84 Million	CN¥927.79 Million ≈ $135.76 Million	0.193x	+9.77%
2014-12-31	CN¥4.08 Billion ≈ $597.39 Million	CN¥717.39 Million ≈ $104.98 Million	0.176x	+43.96%
2013-12-31	CN¥3.60 Billion ≈ $527.45 Million	CN¥439.99 Million ≈ $64.38 Million	0.122x	-34.65%
2012-12-31	CN¥3.18 Billion ≈ $465.35 Million	CN¥593.96 Million ≈ $86.92 Million	0.187x	-20.57%
2011-12-31	CN¥3.01 Billion ≈ $440.69 Million	CN¥708.20 Million ≈ $103.63 Million	0.235x	-2.00%
2010-12-31	CN¥2.64 Billion ≈ $386.19 Million	CN¥633.30 Million ≈ $92.67 Million	0.240x	+7.91%
2009-12-31	CN¥2.23 Billion ≈ $325.65 Million	CN¥494.88 Million ≈ $72.42 Million	0.222x	+18.18%
2008-12-31	CN¥1.83 Billion ≈ $268.45 Million	CN¥345.18 Million ≈ $50.51 Million	0.188x	+50.71%
2007-12-31	CN¥1.99 Billion ≈ $291.33 Million	CN¥248.55 Million ≈ $36.37 Million	0.125x	-24.00%
2006-12-31	CN¥1.38 Billion ≈ $201.72 Million	CN¥226.46 Million ≈ $33.14 Million	0.164x	+26.31%
2005-12-31	CN¥1.24 Billion ≈ $181.22 Million	CN¥161.07 Million ≈ $23.57 Million	0.130x	-16.00%
2004-12-31	CN¥1.17 Billion ≈ $171.49 Million	CN¥181.46 Million ≈ $26.55 Million	0.155x	-39.38%
2003-12-31	CN¥1.17 Billion ≈ $171.87 Million	CN¥300.01 Million ≈ $43.90 Million	0.255x	+35.02%
2002-12-31	CN¥1.13 Billion ≈ $165.26 Million	CN¥213.65 Million ≈ $31.26 Million	0.189x	+26.42%
2001-12-31	CN¥1.04 Billion ≈ $151.72 Million	CN¥155.15 Million ≈ $22.70 Million	0.150x	+291.26%
2000-12-31	CN¥1.01 Billion ≈ $147.36 Million	CN¥38.52 Million ≈ $5.64 Million	0.038x	-84.87%
1999-12-31	CN¥973.90 Million ≈ $142.51 Million	CN¥246.23 Million ≈ $36.03 Million	0.253x	+1580.52%
1998-12-31	CN¥1.07 Billion ≈ $156.05 Million	CN¥-18.21 Million ≈ $-2.66 Million	-0.017x	--

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.81 Billion

CN¥19.20 Billion CNY

Market Cap Rank

#5139 Global

#996 in China

Share Price

CN¥32.65

Change (1 day)

-0.55%

52-Week Range

CN¥32.54 - CN¥43.90

All Time High

CN¥1418.81